Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-Based Decision-Making in Clinical Research
Accelerating Systematic Literature Reviews with an AI-Powered Screening Tool At ISPOR Europe 2025, Paul Loustalot from Quinten Health presented a new AI-powered tool designed to accelerate and enhance systematic literature reviews (SLRs) by semi-automating title and abstract screening. The tool enhances efficiency while preserving the scientific rigor required in evidence-based clinical research. Paul Loustalot presenting […]
Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-Based Decision Making in Clinical Research
Event: ISPOR Europe 2025, Glasgow, Scotland, UK Authors: Paul Loustalot, Boris Kopin, Sacha Levy, Basile Ferry, Vincent Martenot View Poster OBJECTIVES Systematic literature reviews (SLRs) are foundational for evidence-based decisions-making across the pharmaceutical and medical devices product lifecycle, from early research and development to market launch, and post-market activities. Conventional SLRs are often time- and resource-intensive, […]
Existing practices for the identification, selection or assessment of registries for regulatory/HTA purposes: a More-EUROPA project systematic review
Event: ISPOR Europe 2023, Copenhagen, Denmark Authors: S. Zebachi, J. Moreira, J. Tanniou, P. Godbillot, P. Tang, B. Amzal View Poster Objectives Real-world data (RWD), particularly patient registries, represent a potential useful source of information and may be required at various stages of the drug lifecycle. Different questions may be asked throughout the regulatory and/or […]
Existing automated tools to assist evidence generation and better qualification of registries and real-world data. A systematic review from the More-EUROPA project
Event: ISPOR Europe 2023, Copenhagen, Denmark Authors: P. Godbillot, P. Tang, J. Moreira, J. Tanniou S. Zebachi, B. Amzal View Poster Objectives The More-EUROPA project consortium brings together 14 public and private entities from 7 countries with the aim of enhancing the ethical and effective utilization of registry data to facilitate patient-centered decision-making by drug regulators and Health Technology Assessment […]
